B Cell Activating Factor, Renal Allograft Antibody-Mediated Rejection, and Long-Term Outcome

Antibody-mediated rejection (ABMR) of renal allograft lacks typical phenotypes and clinical manifestations, always resulting in delayed diagnosis and treatment. It has been considered to be an elemental factor influencing the improvement of the long-term outcome of renal allograft. The B cell activa...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Haiyan, He, Xiaozhou, Xu, Renfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011068/
https://www.ncbi.nlm.nih.gov/pubmed/29977928
http://dx.doi.org/10.1155/2018/5251801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011068/
https://www.ncbi.nlm.nih.gov/pubmed/29977928
http://dx.doi.org/10.1155/2018/5251801

Ejemplares similares